Search

Zoetis Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

78.06 0.67

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

75.08

Max

77.57

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2M

601M

Pardavimai

-125M

2.3B

P/E

Sektoriaus vid.

12.554

62.58

Pelnas, tenkantis vienai akcijai

1.53

Dividendų pajamingumas

2.67

Pelno marža

26.569

Darbuotojai

14,500

EBITDA

-8M

939M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+33.15% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

2.67%

2.19%

Kitas uždarbis

2026-08-06

Kitas dividendų mokėjimo data

2026-09-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-16B

32B

Ankstesnė atidarymo kaina

77.39

Ankstesnė uždarymo kaina

78.06

Naujienos nuotaikos

By Acuity

56%

44%

269 / 340 reitingas Healthcare

Zoetis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-25 00:01; UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

2026-07-24 21:02; UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

2026-07-23 20:02; UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

2026-07-22 21:02; UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

2026-07-21 17:51; UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

2026-07-20 23:16; UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Akcijų palyginimas

Kainos pokytis

Zoetis Inc Prognozė

Kainos tikslas

By TipRanks

33.15% į viršų

12 mėnesių prognozė

Vidutinis 100.33 USD  33.15%

Aukščiausias 130 USD

Žemiausias 85 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zoetis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

6

Pirkti

6

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

269 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Aukščiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat